Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
National Cancer Institute of Canada Clinical Trials Information presented on Clinical Trials Search isn't meant to be a substitute for certified medical advice, visits or professional assistance with a genuine dr.. We are not docs. Always confer with your mD about National Cancer Institute of Canada clinical studies. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. National Cancer Institute of Canada Clinical research trials and National Cancer Institute of Canada health trials occur in many of localities across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new drugs. The purpose of the studies / undertakings is to resolve specific human health questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies like National Cancer Institute of Canada to locate cures for all forms of conditions. National Cancer Institute of Canada Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the test subjects receive professional assistance for free of charge, and every now and again they are compensated for their time. Sometimes there is a cost for a National Cancer Institute of Canada clinical trial. Test subjects oftentimes recieve the finest healthcare available for their condition. Hazards are a reality, nonetheless, and could include more or frequent dr. trips, health risks (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "N" Clinical Trials Sponsors > National Cancer Institute of Canada Clinical Trials

National Cancer Institute of Canada Clinical Trials



Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Bortezomib in Treating Patients With Mantle Cell Lymphoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

CCI-779 in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Combination Chemotherapy in Treating Patients With Multiple Myeloma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Exemestane Compared With Anastrozole, With or Without Celecoxib, in Treating Postmenopausal Women After Surgery for Primary Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

MG98 in Treating Patients With Advanced Solid Tumors
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiation Therapy Following Surgery in Treating Women With Early-Stage Invasive Breast Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Stage I Endometrial Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Salvage Chemotherapy Using Dexamethasone and Cisplatin Combined With Either Gemcitabine or Cytarabine Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

SarCNU in Treating Patients With Recurrent Malignant Glioma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Single-Fraction Radiation Therapy Compared With Multiple-Fraction Reirradiation Therapy in Treating Patients With Painful Bone Metastases
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Treatment for Chronic Pain in Patients With Advanced Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada

ZD6474 in Treating Patients With Small Cell Lung Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada



National Cancer Institute of Canada Clinical Trials
Modify your Search

Other "N" Clinical Trials Sponsors:

Nabi Biopharmaceuticals
National Cancer Institute (nci)
National Cancer Institute Of Canada
National Cancer Research Institute (ncri)
National Center For Complementary And Alternative Medicine (nccam)
National Center For Research Resources (ncrr)
National Eye Institute (nei)
National Heart, Lung, And Blood Institute (nhlbi)
National Human Genome Research Institute (nhgri)
National Institute Of Allergy And Infectious Diseases (niaid)
National Institute Of Arthritis And Musculoskeletal And Skin Diseases (niams)
National Institute Of Child Health And Human Development (nichd)
National Institute Of Dental And Craniofacial Research (nidcr)
National Institute Of Diabetes And Digestive And Kidney Diseases (niddk)
National Institute Of Environmental Health Sciences (niehs)
National Institute Of Mental Health (nimh)
National Institute Of Neurological Disorders And Stroke (ninds)
National Institute Of Nursing Research (ninr)
National Institute On Aging (nia)
National Institute On Alcohol Abuse And Alcoholism (niaaa)
National Institute On Deafness And Other Communication Disorders (nidcd)
National Institute On Drug Abuse (nida)
National Library Of Medicine (nlm)
National Surgical Adjuvant Breast And Bowel Project (nsabp)
Neopharm
Neorx Corporation
Neotherapeutics
Neurex
Neurochem Inc.
Neurocrine Biosciences
Neurogesx
Neuropace
New Jersey Medical School
New York Gynecological Oncology Group
Newbiotics
Newport Pharmaceuticals International
Nexstar Pharmaceuticals
Nitromed
Nmrc Asia-Pacific Hepatocellular Carcinoma Trials Group
Nmrc Head And Neck Cancer Group
Nmrc International Colorectal Cancer Trials Group
Nmrc Nasopharyngeal Cancer Work Group
Nordic Society For Gynaecologic Oncology
Norris Cotton Cancer Center
North American Brain Tumor Consortium
North Central Cancer Treatment Group
Northfield Laboratories
Northwest Biotherapeutics
Northwestern Memorial Hospital
Northwestern University
Novacea
Novartis Pharmaceuticals
Novo Nordisk Pharmaceuticals
Novogen
Novum
Novuspharma
Nps Allelix Corp.
Nucryst Pharmaceuticals
Nuvelo


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103